INTERNATIONAL JOURNAL OF CANCER-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2122992, encodeId=d2fa21229924d, content=偏重的研究方向：肿瘤相关;Environmental Research 经验分享：请问一下大家，投稿IJC的时候单细胞测序数据必须上传到数据库中吗？还是说等文章确定接收了再上传也行？细胞系鉴定证明有没有模板分享一下？不胜感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Fri Mar 31 18:59:13 CST 2023, time=2023-03-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1214684, encodeId=d4591214684a7, content=偏重的研究方向：肿瘤;Cancer;临床 经验分享：问一下大家under evaluation都持续几天呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Tue Apr 26 19:16:26 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209671, encodeId=2d0612096e128, content=偏重的研究方向：tumor microenironment 经验分享：2022-3-27 submit，当天under evaluation，现在还是此状态，愁了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995720940, createdName=ms9000000300158487, createdTime=Fri Apr 08 21:13:08 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190810, encodeId=4a4511908108b, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：胶质瘤 经验分享：我2022.1.23投稿，到现在状态还是under evaluation，已经15天了，要拒怎么不早点拒，还有希望送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Mon Feb 07 19:27:06 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886186, encodeId=698588618632, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：分享一下我的投稿经历 2020.5.9 submitted to the journal 2020.5.11 under evaluation 2020.5.11 under review 2020.6.7 Awaiting descision 2020.6.11 Major revision 2020.8.10 Revision submitted 2020.8.10 under evaluation 2020.8.13 under review 2020.9.5 Awaiting descision 2020.9.9 Accepted 首次投IJC，投的综述，他们的综述一般是约稿，但是也收散稿，我是提前和编辑部发了邮件自荐的，杂志主编看了后很感兴趣，希望我投稿。审稿人虽然是匿名，但是从comments的言辞之间，让我感觉是其中的一位业界大牛Angelika Amon （Koch Institute MIT）。读了她的意见真是醍醐灌顶，受益良多。所以大修之后基本上改的面目全非，但是文章的创新型提高好几个层次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Thu Sep 17 21:55:09 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586671, encodeId=3c5c5866e132, content=当天下午五点多提交的，七点多变了下状态，evaluation ，八点多就under review 了，没有with editor 这个状态532425342 2020-03-09 发表:: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了532425342 2020-03-09 00:00:00 发表: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了, beContent=532425342 2020-03-09 发表:: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073166, encodeId=104510e3166db, content=杂志效率很高，一周之内基本会给结果要不要送审，我的文章本身数据有些欠缺，编辑给出了充分的理由退回了，说的我心服口服，蛮好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210726/1c70ea73227f4c989cde67fd69067644/6c609f7ecbd34ab682cc9eaf5f800da8.jpg, createdBy=295a1634695, createdName=qinfeng, createdTime=Tue Nov 23 12:20:42 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920246, encodeId=0c2792024672, content=请问：大修后under review 1周又变成under evaluation，有没有小伙伴经历这个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Wed Jan 27 10:37:56 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180835, encodeId=b19b21808352d, content=求问各位大佬，Under evaluation已经12天了，可以催稿么？着急毕业。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2029080835, createdName=ms6000000445449810, createdTime=Thu Jan 11 20:03:35 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2104984, encodeId=504d21049849d, content=偏重的研究方向：mutational signature 经验分享：2022.09.02 submitted 2022.09.04 under evaluation 2022.09.12 under review 2022.09.20 under evaluation 2022.09.21 under review 2022.10.20 awaiting decision 2022.10.25 major revision 2022.11.19 resubmission 2022.11.21 under review 2022.12.2 under evaluation 2022.12.6 under review 2022.12.7 awaiting decision 2022.12.8 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c358198965, createdName=yousuosaki, createdTime=Thu Dec 08 21:00:04 CST 2022, time=2022-12-08, status=1, ipAttribution=海南省)]

2023-03-31 Linyan Yu 来自山东省

偏重的研究方向：肿瘤相关;Environmental Research
经验分享：请问一下大家，投稿IJC的时候单细胞测序数据必须上传到数据库中吗？还是说等文章确定接收了再上传也行？细胞系鉴定证明有没有模板分享一下？不胜感激

64 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122992, encodeId=d2fa21229924d, content=偏重的研究方向：肿瘤相关;Environmental Research 经验分享：请问一下大家，投稿IJC的时候单细胞测序数据必须上传到数据库中吗？还是说等文章确定接收了再上传也行？细胞系鉴定证明有没有模板分享一下？不胜感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Fri Mar 31 18:59:13 CST 2023, time=2023-03-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1214684, encodeId=d4591214684a7, content=偏重的研究方向：肿瘤;Cancer;临床 经验分享：问一下大家under evaluation都持续几天呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Tue Apr 26 19:16:26 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209671, encodeId=2d0612096e128, content=偏重的研究方向：tumor microenironment 经验分享：2022-3-27 submit，当天under evaluation，现在还是此状态，愁了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995720940, createdName=ms9000000300158487, createdTime=Fri Apr 08 21:13:08 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190810, encodeId=4a4511908108b, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：胶质瘤 经验分享：我2022.1.23投稿，到现在状态还是under evaluation，已经15天了，要拒怎么不早点拒，还有希望送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Mon Feb 07 19:27:06 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886186, encodeId=698588618632, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：分享一下我的投稿经历 2020.5.9 submitted to the journal 2020.5.11 under evaluation 2020.5.11 under review 2020.6.7 Awaiting descision 2020.6.11 Major revision 2020.8.10 Revision submitted 2020.8.10 under evaluation 2020.8.13 under review 2020.9.5 Awaiting descision 2020.9.9 Accepted 首次投IJC，投的综述，他们的综述一般是约稿，但是也收散稿，我是提前和编辑部发了邮件自荐的，杂志主编看了后很感兴趣，希望我投稿。审稿人虽然是匿名，但是从comments的言辞之间，让我感觉是其中的一位业界大牛Angelika Amon （Koch Institute MIT）。读了她的意见真是醍醐灌顶，受益良多。所以大修之后基本上改的面目全非，但是文章的创新型提高好几个层次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Thu Sep 17 21:55:09 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586671, encodeId=3c5c5866e132, content=当天下午五点多提交的，七点多变了下状态，evaluation ，八点多就under review 了，没有with editor 这个状态532425342 2020-03-09 发表:: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了532425342 2020-03-09 00:00:00 发表: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了, beContent=532425342 2020-03-09 发表:: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073166, encodeId=104510e3166db, content=杂志效率很高，一周之内基本会给结果要不要送审，我的文章本身数据有些欠缺，编辑给出了充分的理由退回了，说的我心服口服，蛮好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210726/1c70ea73227f4c989cde67fd69067644/6c609f7ecbd34ab682cc9eaf5f800da8.jpg, createdBy=295a1634695, createdName=qinfeng, createdTime=Tue Nov 23 12:20:42 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920246, encodeId=0c2792024672, content=请问：大修后under review 1周又变成under evaluation，有没有小伙伴经历这个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Wed Jan 27 10:37:56 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180835, encodeId=b19b21808352d, content=求问各位大佬，Under evaluation已经12天了，可以催稿么？着急毕业。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2029080835, createdName=ms6000000445449810, createdTime=Thu Jan 11 20:03:35 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2104984, encodeId=504d21049849d, content=偏重的研究方向：mutational signature 经验分享：2022.09.02 submitted 2022.09.04 under evaluation 2022.09.12 under review 2022.09.20 under evaluation 2022.09.21 under review 2022.10.20 awaiting decision 2022.10.25 major revision 2022.11.19 resubmission 2022.11.21 under review 2022.12.2 under evaluation 2022.12.6 under review 2022.12.7 awaiting decision 2022.12.8 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c358198965, createdName=yousuosaki, createdTime=Thu Dec 08 21:00:04 CST 2022, time=2022-12-08, status=1, ipAttribution=海南省)]

2022-04-26 ms9000000399989409

偏重的研究方向：肿瘤;Cancer;临床
经验分享：问一下大家under evaluation都持续几天呢?

98 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122992, encodeId=d2fa21229924d, content=偏重的研究方向：肿瘤相关;Environmental Research 经验分享：请问一下大家，投稿IJC的时候单细胞测序数据必须上传到数据库中吗？还是说等文章确定接收了再上传也行？细胞系鉴定证明有没有模板分享一下？不胜感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Fri Mar 31 18:59:13 CST 2023, time=2023-03-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1214684, encodeId=d4591214684a7, content=偏重的研究方向：肿瘤;Cancer;临床 经验分享：问一下大家under evaluation都持续几天呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Tue Apr 26 19:16:26 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209671, encodeId=2d0612096e128, content=偏重的研究方向：tumor microenironment 经验分享：2022-3-27 submit，当天under evaluation，现在还是此状态，愁了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995720940, createdName=ms9000000300158487, createdTime=Fri Apr 08 21:13:08 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190810, encodeId=4a4511908108b, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：胶质瘤 经验分享：我2022.1.23投稿，到现在状态还是under evaluation，已经15天了，要拒怎么不早点拒，还有希望送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Mon Feb 07 19:27:06 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886186, encodeId=698588618632, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：分享一下我的投稿经历 2020.5.9 submitted to the journal 2020.5.11 under evaluation 2020.5.11 under review 2020.6.7 Awaiting descision 2020.6.11 Major revision 2020.8.10 Revision submitted 2020.8.10 under evaluation 2020.8.13 under review 2020.9.5 Awaiting descision 2020.9.9 Accepted 首次投IJC，投的综述，他们的综述一般是约稿，但是也收散稿，我是提前和编辑部发了邮件自荐的，杂志主编看了后很感兴趣，希望我投稿。审稿人虽然是匿名，但是从comments的言辞之间，让我感觉是其中的一位业界大牛Angelika Amon （Koch Institute MIT）。读了她的意见真是醍醐灌顶，受益良多。所以大修之后基本上改的面目全非，但是文章的创新型提高好几个层次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Thu Sep 17 21:55:09 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586671, encodeId=3c5c5866e132, content=当天下午五点多提交的，七点多变了下状态，evaluation ，八点多就under review 了，没有with editor 这个状态532425342 2020-03-09 发表:: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了532425342 2020-03-09 00:00:00 发表: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了, beContent=532425342 2020-03-09 发表:: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073166, encodeId=104510e3166db, content=杂志效率很高，一周之内基本会给结果要不要送审，我的文章本身数据有些欠缺，编辑给出了充分的理由退回了，说的我心服口服，蛮好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210726/1c70ea73227f4c989cde67fd69067644/6c609f7ecbd34ab682cc9eaf5f800da8.jpg, createdBy=295a1634695, createdName=qinfeng, createdTime=Tue Nov 23 12:20:42 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920246, encodeId=0c2792024672, content=请问：大修后under review 1周又变成under evaluation，有没有小伙伴经历这个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Wed Jan 27 10:37:56 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180835, encodeId=b19b21808352d, content=求问各位大佬，Under evaluation已经12天了，可以催稿么？着急毕业。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2029080835, createdName=ms6000000445449810, createdTime=Thu Jan 11 20:03:35 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2104984, encodeId=504d21049849d, content=偏重的研究方向：mutational signature 经验分享：2022.09.02 submitted 2022.09.04 under evaluation 2022.09.12 under review 2022.09.20 under evaluation 2022.09.21 under review 2022.10.20 awaiting decision 2022.10.25 major revision 2022.11.19 resubmission 2022.11.21 under review 2022.12.2 under evaluation 2022.12.6 under review 2022.12.7 awaiting decision 2022.12.8 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c358198965, createdName=yousuosaki, createdTime=Thu Dec 08 21:00:04 CST 2022, time=2022-12-08, status=1, ipAttribution=海南省)]

2022-04-08 ms9000000300158487

偏重的研究方向：tumor microenironment
经验分享：2022-3-27 submit，当天under evaluation，现在还是此状态，愁了

84 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122992, encodeId=d2fa21229924d, content=偏重的研究方向：肿瘤相关;Environmental Research 经验分享：请问一下大家，投稿IJC的时候单细胞测序数据必须上传到数据库中吗？还是说等文章确定接收了再上传也行？细胞系鉴定证明有没有模板分享一下？不胜感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Fri Mar 31 18:59:13 CST 2023, time=2023-03-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1214684, encodeId=d4591214684a7, content=偏重的研究方向：肿瘤;Cancer;临床 经验分享：问一下大家under evaluation都持续几天呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Tue Apr 26 19:16:26 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209671, encodeId=2d0612096e128, content=偏重的研究方向：tumor microenironment 经验分享：2022-3-27 submit，当天under evaluation，现在还是此状态，愁了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995720940, createdName=ms9000000300158487, createdTime=Fri Apr 08 21:13:08 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190810, encodeId=4a4511908108b, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：胶质瘤 经验分享：我2022.1.23投稿，到现在状态还是under evaluation，已经15天了，要拒怎么不早点拒，还有希望送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Mon Feb 07 19:27:06 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886186, encodeId=698588618632, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：分享一下我的投稿经历 2020.5.9 submitted to the journal 2020.5.11 under evaluation 2020.5.11 under review 2020.6.7 Awaiting descision 2020.6.11 Major revision 2020.8.10 Revision submitted 2020.8.10 under evaluation 2020.8.13 under review 2020.9.5 Awaiting descision 2020.9.9 Accepted 首次投IJC，投的综述，他们的综述一般是约稿，但是也收散稿，我是提前和编辑部发了邮件自荐的，杂志主编看了后很感兴趣，希望我投稿。审稿人虽然是匿名，但是从comments的言辞之间，让我感觉是其中的一位业界大牛Angelika Amon （Koch Institute MIT）。读了她的意见真是醍醐灌顶，受益良多。所以大修之后基本上改的面目全非，但是文章的创新型提高好几个层次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Thu Sep 17 21:55:09 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586671, encodeId=3c5c5866e132, content=当天下午五点多提交的，七点多变了下状态，evaluation ，八点多就under review 了，没有with editor 这个状态532425342 2020-03-09 发表:: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了532425342 2020-03-09 00:00:00 发表: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了, beContent=532425342 2020-03-09 发表:: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073166, encodeId=104510e3166db, content=杂志效率很高，一周之内基本会给结果要不要送审，我的文章本身数据有些欠缺，编辑给出了充分的理由退回了，说的我心服口服，蛮好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210726/1c70ea73227f4c989cde67fd69067644/6c609f7ecbd34ab682cc9eaf5f800da8.jpg, createdBy=295a1634695, createdName=qinfeng, createdTime=Tue Nov 23 12:20:42 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920246, encodeId=0c2792024672, content=请问：大修后under review 1周又变成under evaluation，有没有小伙伴经历这个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Wed Jan 27 10:37:56 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180835, encodeId=b19b21808352d, content=求问各位大佬，Under evaluation已经12天了，可以催稿么？着急毕业。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2029080835, createdName=ms6000000445449810, createdTime=Thu Jan 11 20:03:35 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2104984, encodeId=504d21049849d, content=偏重的研究方向：mutational signature 经验分享：2022.09.02 submitted 2022.09.04 under evaluation 2022.09.12 under review 2022.09.20 under evaluation 2022.09.21 under review 2022.10.20 awaiting decision 2022.10.25 major revision 2022.11.19 resubmission 2022.11.21 under review 2022.12.2 under evaluation 2022.12.6 under review 2022.12.7 awaiting decision 2022.12.8 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c358198965, createdName=yousuosaki, createdTime=Thu Dec 08 21:00:04 CST 2022, time=2022-12-08, status=1, ipAttribution=海南省)]

2022-02-07 ms4000001980332372

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：胶质瘤
经验分享：我2022.1.23投稿，到现在状态还是under evaluation，已经15天了，要拒怎么不早点拒，还有希望送审吗

84 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122992, encodeId=d2fa21229924d, content=偏重的研究方向：肿瘤相关;Environmental Research 经验分享：请问一下大家，投稿IJC的时候单细胞测序数据必须上传到数据库中吗？还是说等文章确定接收了再上传也行？细胞系鉴定证明有没有模板分享一下？不胜感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Fri Mar 31 18:59:13 CST 2023, time=2023-03-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1214684, encodeId=d4591214684a7, content=偏重的研究方向：肿瘤;Cancer;临床 经验分享：问一下大家under evaluation都持续几天呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Tue Apr 26 19:16:26 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209671, encodeId=2d0612096e128, content=偏重的研究方向：tumor microenironment 经验分享：2022-3-27 submit，当天under evaluation，现在还是此状态，愁了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995720940, createdName=ms9000000300158487, createdTime=Fri Apr 08 21:13:08 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190810, encodeId=4a4511908108b, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：胶质瘤 经验分享：我2022.1.23投稿，到现在状态还是under evaluation，已经15天了，要拒怎么不早点拒，还有希望送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Mon Feb 07 19:27:06 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886186, encodeId=698588618632, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：分享一下我的投稿经历 2020.5.9 submitted to the journal 2020.5.11 under evaluation 2020.5.11 under review 2020.6.7 Awaiting descision 2020.6.11 Major revision 2020.8.10 Revision submitted 2020.8.10 under evaluation 2020.8.13 under review 2020.9.5 Awaiting descision 2020.9.9 Accepted 首次投IJC，投的综述，他们的综述一般是约稿，但是也收散稿，我是提前和编辑部发了邮件自荐的，杂志主编看了后很感兴趣，希望我投稿。审稿人虽然是匿名，但是从comments的言辞之间，让我感觉是其中的一位业界大牛Angelika Amon （Koch Institute MIT）。读了她的意见真是醍醐灌顶，受益良多。所以大修之后基本上改的面目全非，但是文章的创新型提高好几个层次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Thu Sep 17 21:55:09 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586671, encodeId=3c5c5866e132, content=当天下午五点多提交的，七点多变了下状态，evaluation ，八点多就under review 了，没有with editor 这个状态532425342 2020-03-09 发表:: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了532425342 2020-03-09 00:00:00 发表: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了, beContent=532425342 2020-03-09 发表:: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073166, encodeId=104510e3166db, content=杂志效率很高，一周之内基本会给结果要不要送审，我的文章本身数据有些欠缺，编辑给出了充分的理由退回了，说的我心服口服，蛮好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210726/1c70ea73227f4c989cde67fd69067644/6c609f7ecbd34ab682cc9eaf5f800da8.jpg, createdBy=295a1634695, createdName=qinfeng, createdTime=Tue Nov 23 12:20:42 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920246, encodeId=0c2792024672, content=请问：大修后under review 1周又变成under evaluation，有没有小伙伴经历这个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Wed Jan 27 10:37:56 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180835, encodeId=b19b21808352d, content=求问各位大佬，Under evaluation已经12天了，可以催稿么？着急毕业。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2029080835, createdName=ms6000000445449810, createdTime=Thu Jan 11 20:03:35 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2104984, encodeId=504d21049849d, content=偏重的研究方向：mutational signature 经验分享：2022.09.02 submitted 2022.09.04 under evaluation 2022.09.12 under review 2022.09.20 under evaluation 2022.09.21 under review 2022.10.20 awaiting decision 2022.10.25 major revision 2022.11.19 resubmission 2022.11.21 under review 2022.12.2 under evaluation 2022.12.6 under review 2022.12.7 awaiting decision 2022.12.8 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c358198965, createdName=yousuosaki, createdTime=Thu Dec 08 21:00:04 CST 2022, time=2022-12-08, status=1, ipAttribution=海南省)]

2020-09-17 da-xiang

审稿速度:6.0 | 投稿命中率:25.0
经验分享：分享一下我的投稿经历
2020.5.9 submitted to the journal
2020.5.11 under evaluation
2020.5.11 under review
2020.6.7 Awaiting descision
2020.6.11 Major revision
2020.8.10 Revision submitted
2020.8.10 under evaluation
2020.8.13 under review
2020.9.5 Awaiting descision
2020.9.9 Accepted
首次投IJC，投的综述，他们的综述一般是约稿，但是也收散稿，我是提前和编辑部发了邮件自荐的，杂志主编看了后很感兴趣，希望我投稿。审稿人虽然是匿名，但是从comments的言辞之间，让我感觉是其中的一位业界大牛Angelika Amon （Koch Institute MIT）。读了她的意见真是醍醐灌顶，受益良多。所以大修之后基本上改的面目全非，但是文章的创新型提高好几个层次。

5 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122992, encodeId=d2fa21229924d, content=偏重的研究方向：肿瘤相关;Environmental Research 经验分享：请问一下大家，投稿IJC的时候单细胞测序数据必须上传到数据库中吗？还是说等文章确定接收了再上传也行？细胞系鉴定证明有没有模板分享一下？不胜感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Fri Mar 31 18:59:13 CST 2023, time=2023-03-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1214684, encodeId=d4591214684a7, content=偏重的研究方向：肿瘤;Cancer;临床 经验分享：问一下大家under evaluation都持续几天呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Tue Apr 26 19:16:26 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209671, encodeId=2d0612096e128, content=偏重的研究方向：tumor microenironment 经验分享：2022-3-27 submit，当天under evaluation，现在还是此状态，愁了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995720940, createdName=ms9000000300158487, createdTime=Fri Apr 08 21:13:08 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190810, encodeId=4a4511908108b, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：胶质瘤 经验分享：我2022.1.23投稿，到现在状态还是under evaluation，已经15天了，要拒怎么不早点拒，还有希望送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Mon Feb 07 19:27:06 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886186, encodeId=698588618632, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：分享一下我的投稿经历 2020.5.9 submitted to the journal 2020.5.11 under evaluation 2020.5.11 under review 2020.6.7 Awaiting descision 2020.6.11 Major revision 2020.8.10 Revision submitted 2020.8.10 under evaluation 2020.8.13 under review 2020.9.5 Awaiting descision 2020.9.9 Accepted 首次投IJC，投的综述，他们的综述一般是约稿，但是也收散稿，我是提前和编辑部发了邮件自荐的，杂志主编看了后很感兴趣，希望我投稿。审稿人虽然是匿名，但是从comments的言辞之间，让我感觉是其中的一位业界大牛Angelika Amon （Koch Institute MIT）。读了她的意见真是醍醐灌顶，受益良多。所以大修之后基本上改的面目全非，但是文章的创新型提高好几个层次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Thu Sep 17 21:55:09 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586671, encodeId=3c5c5866e132, content=当天下午五点多提交的，七点多变了下状态，evaluation ，八点多就under review 了，没有with editor 这个状态532425342 2020-03-09 发表:: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了532425342 2020-03-09 00:00:00 发表: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了, beContent=532425342 2020-03-09 发表:: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073166, encodeId=104510e3166db, content=杂志效率很高，一周之内基本会给结果要不要送审，我的文章本身数据有些欠缺，编辑给出了充分的理由退回了，说的我心服口服，蛮好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210726/1c70ea73227f4c989cde67fd69067644/6c609f7ecbd34ab682cc9eaf5f800da8.jpg, createdBy=295a1634695, createdName=qinfeng, createdTime=Tue Nov 23 12:20:42 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920246, encodeId=0c2792024672, content=请问：大修后under review 1周又变成under evaluation，有没有小伙伴经历这个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Wed Jan 27 10:37:56 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180835, encodeId=b19b21808352d, content=求问各位大佬，Under evaluation已经12天了，可以催稿么？着急毕业。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2029080835, createdName=ms6000000445449810, createdTime=Thu Jan 11 20:03:35 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2104984, encodeId=504d21049849d, content=偏重的研究方向：mutational signature 经验分享：2022.09.02 submitted 2022.09.04 under evaluation 2022.09.12 under review 2022.09.20 under evaluation 2022.09.21 under review 2022.10.20 awaiting decision 2022.10.25 major revision 2022.11.19 resubmission 2022.11.21 under review 2022.12.2 under evaluation 2022.12.6 under review 2022.12.7 awaiting decision 2022.12.8 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c358198965, createdName=yousuosaki, createdTime=Thu Dec 08 21:00:04 CST 2022, time=2022-12-08, status=1, ipAttribution=海南省)]

2020-03-15 兮牧歌

当天下午五点多提交的，七点多变了下状态，evaluation ，八点多就under review 了，没有with editor 这个状态532425342 2020-03-09 发表::
请问你是提交后多久under review的？听说一周不拒就有可能是送外审了532425342 2020-03-09 00:00:00 发表:
请问你是提交后多久under review的？听说一周不拒就有可能是送外审了

532425342 2020-03-09 发表:: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了

129 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122992, encodeId=d2fa21229924d, content=偏重的研究方向：肿瘤相关;Environmental Research 经验分享：请问一下大家，投稿IJC的时候单细胞测序数据必须上传到数据库中吗？还是说等文章确定接收了再上传也行？细胞系鉴定证明有没有模板分享一下？不胜感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Fri Mar 31 18:59:13 CST 2023, time=2023-03-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1214684, encodeId=d4591214684a7, content=偏重的研究方向：肿瘤;Cancer;临床 经验分享：问一下大家under evaluation都持续几天呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Tue Apr 26 19:16:26 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209671, encodeId=2d0612096e128, content=偏重的研究方向：tumor microenironment 经验分享：2022-3-27 submit，当天under evaluation，现在还是此状态，愁了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995720940, createdName=ms9000000300158487, createdTime=Fri Apr 08 21:13:08 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190810, encodeId=4a4511908108b, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：胶质瘤 经验分享：我2022.1.23投稿，到现在状态还是under evaluation，已经15天了，要拒怎么不早点拒，还有希望送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Mon Feb 07 19:27:06 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886186, encodeId=698588618632, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：分享一下我的投稿经历 2020.5.9 submitted to the journal 2020.5.11 under evaluation 2020.5.11 under review 2020.6.7 Awaiting descision 2020.6.11 Major revision 2020.8.10 Revision submitted 2020.8.10 under evaluation 2020.8.13 under review 2020.9.5 Awaiting descision 2020.9.9 Accepted 首次投IJC，投的综述，他们的综述一般是约稿，但是也收散稿，我是提前和编辑部发了邮件自荐的，杂志主编看了后很感兴趣，希望我投稿。审稿人虽然是匿名，但是从comments的言辞之间，让我感觉是其中的一位业界大牛Angelika Amon （Koch Institute MIT）。读了她的意见真是醍醐灌顶，受益良多。所以大修之后基本上改的面目全非，但是文章的创新型提高好几个层次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Thu Sep 17 21:55:09 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586671, encodeId=3c5c5866e132, content=当天下午五点多提交的，七点多变了下状态，evaluation ，八点多就under review 了，没有with editor 这个状态532425342 2020-03-09 发表:: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了532425342 2020-03-09 00:00:00 发表: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了, beContent=532425342 2020-03-09 发表:: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073166, encodeId=104510e3166db, content=杂志效率很高，一周之内基本会给结果要不要送审，我的文章本身数据有些欠缺，编辑给出了充分的理由退回了，说的我心服口服，蛮好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210726/1c70ea73227f4c989cde67fd69067644/6c609f7ecbd34ab682cc9eaf5f800da8.jpg, createdBy=295a1634695, createdName=qinfeng, createdTime=Tue Nov 23 12:20:42 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920246, encodeId=0c2792024672, content=请问：大修后under review 1周又变成under evaluation，有没有小伙伴经历这个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Wed Jan 27 10:37:56 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180835, encodeId=b19b21808352d, content=求问各位大佬，Under evaluation已经12天了，可以催稿么？着急毕业。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2029080835, createdName=ms6000000445449810, createdTime=Thu Jan 11 20:03:35 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2104984, encodeId=504d21049849d, content=偏重的研究方向：mutational signature 经验分享：2022.09.02 submitted 2022.09.04 under evaluation 2022.09.12 under review 2022.09.20 under evaluation 2022.09.21 under review 2022.10.20 awaiting decision 2022.10.25 major revision 2022.11.19 resubmission 2022.11.21 under review 2022.12.2 under evaluation 2022.12.6 under review 2022.12.7 awaiting decision 2022.12.8 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c358198965, createdName=yousuosaki, createdTime=Thu Dec 08 21:00:04 CST 2022, time=2022-12-08, status=1, ipAttribution=海南省)]

2021-11-23 qinfeng

杂志效率很高，一周之内基本会给结果要不要送审，我的文章本身数据有些欠缺，编辑给出了充分的理由退回了，说的我心服口服，蛮好的杂志

49 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122992, encodeId=d2fa21229924d, content=偏重的研究方向：肿瘤相关;Environmental Research 经验分享：请问一下大家，投稿IJC的时候单细胞测序数据必须上传到数据库中吗？还是说等文章确定接收了再上传也行？细胞系鉴定证明有没有模板分享一下？不胜感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Fri Mar 31 18:59:13 CST 2023, time=2023-03-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1214684, encodeId=d4591214684a7, content=偏重的研究方向：肿瘤;Cancer;临床 经验分享：问一下大家under evaluation都持续几天呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Tue Apr 26 19:16:26 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209671, encodeId=2d0612096e128, content=偏重的研究方向：tumor microenironment 经验分享：2022-3-27 submit，当天under evaluation，现在还是此状态，愁了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995720940, createdName=ms9000000300158487, createdTime=Fri Apr 08 21:13:08 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190810, encodeId=4a4511908108b, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：胶质瘤 经验分享：我2022.1.23投稿，到现在状态还是under evaluation，已经15天了，要拒怎么不早点拒，还有希望送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Mon Feb 07 19:27:06 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886186, encodeId=698588618632, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：分享一下我的投稿经历 2020.5.9 submitted to the journal 2020.5.11 under evaluation 2020.5.11 under review 2020.6.7 Awaiting descision 2020.6.11 Major revision 2020.8.10 Revision submitted 2020.8.10 under evaluation 2020.8.13 under review 2020.9.5 Awaiting descision 2020.9.9 Accepted 首次投IJC，投的综述，他们的综述一般是约稿，但是也收散稿，我是提前和编辑部发了邮件自荐的，杂志主编看了后很感兴趣，希望我投稿。审稿人虽然是匿名，但是从comments的言辞之间，让我感觉是其中的一位业界大牛Angelika Amon （Koch Institute MIT）。读了她的意见真是醍醐灌顶，受益良多。所以大修之后基本上改的面目全非，但是文章的创新型提高好几个层次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Thu Sep 17 21:55:09 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586671, encodeId=3c5c5866e132, content=当天下午五点多提交的，七点多变了下状态，evaluation ，八点多就under review 了，没有with editor 这个状态532425342 2020-03-09 发表:: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了532425342 2020-03-09 00:00:00 发表: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了, beContent=532425342 2020-03-09 发表:: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073166, encodeId=104510e3166db, content=杂志效率很高，一周之内基本会给结果要不要送审，我的文章本身数据有些欠缺，编辑给出了充分的理由退回了，说的我心服口服，蛮好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210726/1c70ea73227f4c989cde67fd69067644/6c609f7ecbd34ab682cc9eaf5f800da8.jpg, createdBy=295a1634695, createdName=qinfeng, createdTime=Tue Nov 23 12:20:42 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920246, encodeId=0c2792024672, content=请问：大修后under review 1周又变成under evaluation，有没有小伙伴经历这个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Wed Jan 27 10:37:56 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180835, encodeId=b19b21808352d, content=求问各位大佬，Under evaluation已经12天了，可以催稿么？着急毕业。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2029080835, createdName=ms6000000445449810, createdTime=Thu Jan 11 20:03:35 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2104984, encodeId=504d21049849d, content=偏重的研究方向：mutational signature 经验分享：2022.09.02 submitted 2022.09.04 under evaluation 2022.09.12 under review 2022.09.20 under evaluation 2022.09.21 under review 2022.10.20 awaiting decision 2022.10.25 major revision 2022.11.19 resubmission 2022.11.21 under review 2022.12.2 under evaluation 2022.12.6 under review 2022.12.7 awaiting decision 2022.12.8 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c358198965, createdName=yousuosaki, createdTime=Thu Dec 08 21:00:04 CST 2022, time=2022-12-08, status=1, ipAttribution=海南省)]

2021-01-27 148763b0m69(暂无昵称)

请问：大修后under review 1周又变成under evaluation，有没有小伙伴经历这个？

109 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122992, encodeId=d2fa21229924d, content=偏重的研究方向：肿瘤相关;Environmental Research 经验分享：请问一下大家，投稿IJC的时候单细胞测序数据必须上传到数据库中吗？还是说等文章确定接收了再上传也行？细胞系鉴定证明有没有模板分享一下？不胜感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Fri Mar 31 18:59:13 CST 2023, time=2023-03-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1214684, encodeId=d4591214684a7, content=偏重的研究方向：肿瘤;Cancer;临床 经验分享：问一下大家under evaluation都持续几天呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Tue Apr 26 19:16:26 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209671, encodeId=2d0612096e128, content=偏重的研究方向：tumor microenironment 经验分享：2022-3-27 submit，当天under evaluation，现在还是此状态，愁了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995720940, createdName=ms9000000300158487, createdTime=Fri Apr 08 21:13:08 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190810, encodeId=4a4511908108b, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：胶质瘤 经验分享：我2022.1.23投稿，到现在状态还是under evaluation，已经15天了，要拒怎么不早点拒，还有希望送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Mon Feb 07 19:27:06 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886186, encodeId=698588618632, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：分享一下我的投稿经历 2020.5.9 submitted to the journal 2020.5.11 under evaluation 2020.5.11 under review 2020.6.7 Awaiting descision 2020.6.11 Major revision 2020.8.10 Revision submitted 2020.8.10 under evaluation 2020.8.13 under review 2020.9.5 Awaiting descision 2020.9.9 Accepted 首次投IJC，投的综述，他们的综述一般是约稿，但是也收散稿，我是提前和编辑部发了邮件自荐的，杂志主编看了后很感兴趣，希望我投稿。审稿人虽然是匿名，但是从comments的言辞之间，让我感觉是其中的一位业界大牛Angelika Amon （Koch Institute MIT）。读了她的意见真是醍醐灌顶，受益良多。所以大修之后基本上改的面目全非，但是文章的创新型提高好几个层次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Thu Sep 17 21:55:09 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586671, encodeId=3c5c5866e132, content=当天下午五点多提交的，七点多变了下状态，evaluation ，八点多就under review 了，没有with editor 这个状态532425342 2020-03-09 发表:: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了532425342 2020-03-09 00:00:00 发表: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了, beContent=532425342 2020-03-09 发表:: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073166, encodeId=104510e3166db, content=杂志效率很高，一周之内基本会给结果要不要送审，我的文章本身数据有些欠缺，编辑给出了充分的理由退回了，说的我心服口服，蛮好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210726/1c70ea73227f4c989cde67fd69067644/6c609f7ecbd34ab682cc9eaf5f800da8.jpg, createdBy=295a1634695, createdName=qinfeng, createdTime=Tue Nov 23 12:20:42 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920246, encodeId=0c2792024672, content=请问：大修后under review 1周又变成under evaluation，有没有小伙伴经历这个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Wed Jan 27 10:37:56 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180835, encodeId=b19b21808352d, content=求问各位大佬，Under evaluation已经12天了，可以催稿么？着急毕业。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2029080835, createdName=ms6000000445449810, createdTime=Thu Jan 11 20:03:35 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2104984, encodeId=504d21049849d, content=偏重的研究方向：mutational signature 经验分享：2022.09.02 submitted 2022.09.04 under evaluation 2022.09.12 under review 2022.09.20 under evaluation 2022.09.21 under review 2022.10.20 awaiting decision 2022.10.25 major revision 2022.11.19 resubmission 2022.11.21 under review 2022.12.2 under evaluation 2022.12.6 under review 2022.12.7 awaiting decision 2022.12.8 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c358198965, createdName=yousuosaki, createdTime=Thu Dec 08 21:00:04 CST 2022, time=2022-12-08, status=1, ipAttribution=海南省)]

2024-01-11 ms6000000445449810 来自北京

求问各位大佬，Under evaluation已经12天了，可以催稿么？着急毕业。。。

33 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122992, encodeId=d2fa21229924d, content=偏重的研究方向：肿瘤相关;Environmental Research 经验分享：请问一下大家，投稿IJC的时候单细胞测序数据必须上传到数据库中吗？还是说等文章确定接收了再上传也行？细胞系鉴定证明有没有模板分享一下？不胜感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Fri Mar 31 18:59:13 CST 2023, time=2023-03-31, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1214684, encodeId=d4591214684a7, content=偏重的研究方向：肿瘤;Cancer;临床 经验分享：问一下大家under evaluation都持续几天呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2925481605, createdName=ms9000000399989409, createdTime=Tue Apr 26 19:16:26 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209671, encodeId=2d0612096e128, content=偏重的研究方向：tumor microenironment 经验分享：2022-3-27 submit，当天under evaluation，现在还是此状态，愁了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2995720940, createdName=ms9000000300158487, createdTime=Fri Apr 08 21:13:08 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190810, encodeId=4a4511908108b, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：胶质瘤 经验分享：我2022.1.23投稿，到现在状态还是under evaluation，已经15天了，要拒怎么不早点拒，还有希望送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Mon Feb 07 19:27:06 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886186, encodeId=698588618632, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：分享一下我的投稿经历 2020.5.9 submitted to the journal 2020.5.11 under evaluation 2020.5.11 under review 2020.6.7 Awaiting descision 2020.6.11 Major revision 2020.8.10 Revision submitted 2020.8.10 under evaluation 2020.8.13 under review 2020.9.5 Awaiting descision 2020.9.9 Accepted 首次投IJC，投的综述，他们的综述一般是约稿，但是也收散稿，我是提前和编辑部发了邮件自荐的，杂志主编看了后很感兴趣，希望我投稿。审稿人虽然是匿名，但是从comments的言辞之间，让我感觉是其中的一位业界大牛Angelika Amon （Koch Institute MIT）。读了她的意见真是醍醐灌顶，受益良多。所以大修之后基本上改的面目全非，但是文章的创新型提高好几个层次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Thu Sep 17 21:55:09 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586671, encodeId=3c5c5866e132, content=当天下午五点多提交的，七点多变了下状态，evaluation ，八点多就under review 了，没有with editor 这个状态532425342 2020-03-09 发表:: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了532425342 2020-03-09 00:00:00 发表: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了, beContent=532425342 2020-03-09 发表:: 请问你是提交后多久under review的？听说一周不拒就有可能是送外审了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073166, encodeId=104510e3166db, content=杂志效率很高，一周之内基本会给结果要不要送审，我的文章本身数据有些欠缺，编辑给出了充分的理由退回了，说的我心服口服，蛮好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210726/1c70ea73227f4c989cde67fd69067644/6c609f7ecbd34ab682cc9eaf5f800da8.jpg, createdBy=295a1634695, createdName=qinfeng, createdTime=Tue Nov 23 12:20:42 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920246, encodeId=0c2792024672, content=请问：大修后under review 1周又变成under evaluation，有没有小伙伴经历这个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Wed Jan 27 10:37:56 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180835, encodeId=b19b21808352d, content=求问各位大佬，Under evaluation已经12天了，可以催稿么？着急毕业。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2029080835, createdName=ms6000000445449810, createdTime=Thu Jan 11 20:03:35 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2104984, encodeId=504d21049849d, content=偏重的研究方向：mutational signature 经验分享：2022.09.02 submitted 2022.09.04 under evaluation 2022.09.12 under review 2022.09.20 under evaluation 2022.09.21 under review 2022.10.20 awaiting decision 2022.10.25 major revision 2022.11.19 resubmission 2022.11.21 under review 2022.12.2 under evaluation 2022.12.6 under review 2022.12.7 awaiting decision 2022.12.8 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c358198965, createdName=yousuosaki, createdTime=Thu Dec 08 21:00:04 CST 2022, time=2022-12-08, status=1, ipAttribution=海南省)]

2022-12-08 yousuosaki 来自海南省

偏重的研究方向：mutational signature
经验分享：2022.09.02 submitted
2022.09.04 under evaluation
2022.09.12 under review
2022.09.20 under evaluation
2022.09.21 under review
2022.10.20 awaiting decision
2022.10.25 major revision
2022.11.19 resubmission
2022.11.21 under review
2022.12.2 under evaluation
2022.12.6 under review
2022.12.7 awaiting decision
2022.12.8 accepted

83 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务